RHY 6.06% 6.2¢ rhythm biosciences limited

Future Announcements, page-10

  1. 280 Posts.
    lightbulb Created with Sketch. 95
    To your point @goedy there is a single part-government-funded DNA test 'Cologuard' in the US, however, it's a POO test costing around $500. Insurance companies like it because it's cheaper than a colonoscopy.

    The various DNA PLASMA (blood) tests in development to date are not good at detecting advanced adenomas (pre-cancerous polyps), they only achieve around 20% sensitivity. The whole point of population screening is early detection.

    Rhythm's Colostat on the other hand achieves 87.5% sensitivity for Stage 1, so we can assume at least 60% for advanced adenomas. It offers cheap ELISA-based (readily available), and accurate testing.

    Note - Cologuard only achieves 42% sensitivity for advanced adenomas.

    Rhythm is now on a mission to manufacture a new automated version of its test kit and then collect the required data regarding the reliability of the device itself. I believe the data will easily meet the IVDR requirements.

    Last edited by josiejow37: 09/03/24
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
6.2¢
Change
-0.004(6.06%)
Mkt cap ! $15.41M
Open High Low Value Volume
6.3¢ 6.5¢ 6.0¢ $27.02K 433.8K

Buyers (Bids)

No. Vol. Price($)
4 132970 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.2¢ 32871 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.